Ignite Creation Date:
2025-12-24 @ 12:50 PM
Ignite Modification Date:
2026-02-22 @ 6:36 PM
Study NCT ID:
NCT02805361
Status:
COMPLETED
Last Update Posted:
2019-07-15
First Post:
2016-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-13
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-09
First Submit QC Date:
None
Study First Post Date:
2016-06-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-12
Last Update Post Date:
2019-07-15
Last Update Post Date Type:
ACTUAL